FDA Gives 510(k) Clearance to Therapy Cool Flex Ablation Catheter

The U.S. Food and Drug Administration has cleared Irvine (Calif.) Biomedical to market its Therapy Cool Flex Ablation Catheter as a treatment for typical atrial flutter.

Advertisement

The Cool Flex Ablation Catheter is inserted through a blood vessel and manually maneuvered into the heart. It finds the source of the abnormal heart rhythm and destroys small areas of heart tissue to treat the arrhythmia.

A clinical study found typical atrial flutter was corrected within 30 minutes in 98 percent of patients after undergoing cardiac catheter ablation treatment, according to the report.

More Articles on FDA Approvals:

FDA Approves First Gel Sealant for Leaking Cornea After Cataract Surgery
FDA New Drug Approvals Decline in 2013
FDA Approves EarlySense Bedside Monitor

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.